VRTX Buybacks
19 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–19; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | 2026-03-31 | Reported repurchase cash | $336.9M |
| VERTEX PHARMACEUTICALS INC / MA | 2025-12-31 | Reported repurchase cash | $128.4M |
| VERTEX PHARMACEUTICALS INC / MA | 2025-03-31 | Reported repurchase cash | $426.1M |
| VERTEX PHARMACEUTICALS INC / MA | 2024-12-31 | Reported repurchase cash | $417.9M |
| VERTEX PHARMACEUTICALS INC / MA | 2024-03-31 | Reported repurchase cash | $131.2M |
| VERTEX PHARMACEUTICALS INC / MA | 2023-12-31 | Reported repurchase cash | $149.5M |
| VERTEX PHARMACEUTICALS INC / MA | 2023-03-31 | Reported repurchase cash | $132.8M |
| VERTEX PHARMACEUTICALS INC / MA | 2022-12-31 | Reported repurchase cash | $0.00 |
| VERTEX PHARMACEUTICALS INC / MA | 2022-03-31 | Reported repurchase cash | $0.00 |
| VERTEX PHARMACEUTICALS INC / MA | 2021-12-31 | Reported repurchase cash | $368.2M |
| VERTEX PHARMACEUTICALS INC / MA | 2021-03-31 | Reported repurchase cash | $424.9M |
| VERTEX PHARMACEUTICALS INC / MA | 2020-12-31 | Reported repurchase cash | $131.07M |
| VERTEX PHARMACEUTICALS INC / MA | 2020-03-31 | Reported repurchase cash | $300.03M |
| VERTEX PHARMACEUTICALS INC / MA | 2019-12-31 | Reported repurchase cash | $35.98M |
| VERTEX PHARMACEUTICALS INC / MA | 2019-03-31 | Reported repurchase cash | $94.01M |
| VERTEX PHARMACEUTICALS INC / MA | 2018-12-31 | Reported repurchase cash | $143.01M |
| VERTEX PHARMACEUTICALS INC / MA | 2018-03-31 | Reported repurchase cash | $10M |
| VERTEX PHARMACEUTICALS INC / MA | 2017-12-31 | Reported repurchase cash | $0.00 |
| VERTEX PHARMACEUTICALS INC / MA | 2017-03-31 | Reported repurchase cash | $0.00 |